HUP0401946A2 - Escitalopramot tartalmazó kristályos gyógyszerkészítmény - Google Patents

Escitalopramot tartalmazó kristályos gyógyszerkészítmény

Info

Publication number
HUP0401946A2
HUP0401946A2 HU0401946A HUP0401946A HUP0401946A2 HU P0401946 A2 HUP0401946 A2 HU P0401946A2 HU 0401946 A HU0401946 A HU 0401946A HU P0401946 A HUP0401946 A HU P0401946A HU P0401946 A2 HUP0401946 A2 HU P0401946A2
Authority
HU
Hungary
Prior art keywords
oxalate
escitalopram
well
temperature
crystalline
Prior art date
Application number
HU0401946A
Other languages
English (en)
Inventor
Troels Volsgaard Christensen
Ken Liljegren
Michiel Onne Elema
Lene Andresen
Shashank Mahashabde
Sebastian P. Assenza
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0401946(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of HUP0401946A2 publication Critical patent/HUP0401946A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

A találmány az escitalopram (nemzetközi szabad név), azaz a jól ismertantidepresszáns hatású citalopram S-enantiomerje oxalátsójának,szabatos kémiai névvel (S)-1-[3-(dimetilamino)propil]-1- -(4-fluorfenil)-1,3-dihidro-5-izobenzofuránkarbonitril-oxalátnakkristályos szemcséire, valamint ilyen kristályos szemcsékettartalmazó, szilárd halmazállapotú gyógyászati készítményekre, továbbáa kristályos szemcsék előállítására vonatkozik. Az escitalopram-oxalátkristályos szemcséinek átlagos szemcsemérete legalább 40 mm, előnyösen50 mm és 250 mm közötti. Az eljárás abban áll, hogy escitalopram-oxalát egy alkalmas oldószer-rendszerrel készült oldatát egy elsőhőmérsékletről fokozatosan lehűtik egy második hőmérsékletre,szabályozott hűtési profilt tartva, és az escitalopram-oxalát említettoldatát beojtják escitalopramoxalát kristályai hozzáadása útján alehűtés során, majd az említett második hőmérsékleten a rendszertadott időn át állni hagyják. Ó
HU0401946A 2001-07-31 2002-07-25 Escitalopramot tartalmazó kristályos gyógyszerkészítmény HUP0401946A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101164 2001-07-31
PCT/DK2002/000513 WO2003011278A1 (en) 2001-07-31 2002-07-25 Crystalline composition containing escitalopram

Publications (1)

Publication Number Publication Date
HUP0401946A2 true HUP0401946A2 (hu) 2005-01-28

Family

ID=8160647

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401946A HUP0401946A2 (hu) 2001-07-31 2002-07-25 Escitalopramot tartalmazó kristályos gyógyszerkészítmény

Country Status (40)

Country Link
US (3) US6916941B2 (hu)
EP (2) EP1522539B1 (hu)
JP (4) JP2005525993A (hu)
KR (1) KR20040028947A (hu)
CN (2) CN1311819C (hu)
AR (1) AR034898A1 (hu)
AT (2) ATE352546T1 (hu)
AU (1) AU2002355624B2 (hu)
BG (1) BG108571A (hu)
BR (1) BR0206164A (hu)
CA (1) CA2451915C (hu)
CO (1) CO5560540A2 (hu)
CY (1) CY1106413T1 (hu)
DE (2) DE60217932T2 (hu)
DK (2) DK1414435T3 (hu)
EA (1) EA006213B1 (hu)
EG (1) EG24206A (hu)
ES (2) ES2280892T3 (hu)
HK (1) HK1070000A1 (hu)
HR (2) HRP20031073A2 (hu)
HU (1) HUP0401946A2 (hu)
IL (2) IL159326A0 (hu)
IS (1) IS7077A (hu)
MA (1) MA27349A1 (hu)
ME (1) MEP2108A (hu)
MX (1) MXPA04000849A (hu)
MY (1) MY126238A (hu)
NO (1) NO328346B1 (hu)
NZ (1) NZ530157A (hu)
PE (1) PE20030304A1 (hu)
PL (1) PL366995A1 (hu)
PT (2) PT1414435E (hu)
RS (1) RS8304A (hu)
SI (1) SI1414435T1 (hu)
TN (1) TNSN04021A1 (hu)
TR (1) TR200400189T2 (hu)
UA (1) UA79930C2 (hu)
UY (1) UY27404A1 (hu)
WO (1) WO2003011278A1 (hu)
ZA (1) ZA200309684B (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200102957T2 (tr) 1999-04-14 2004-12-21 H. Lundbeck A/S Sitalopram hazırlanması için metod.
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
US20030109577A1 (en) * 2000-10-27 2003-06-12 Ken Liljegren Pharmaceutical composition containing citalopram
ES2280892T3 (es) 2001-07-31 2007-09-16 H. Lundbeck A/S Composicion cristalina que contiene escitalopram.
TWI306846B (en) 2002-08-12 2009-03-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
TWI339651B (en) * 2004-02-12 2011-04-01 Lundbeck & Co As H Method for the separation of intermediates which may be used for the preparation of escitalopram
US20050196453A1 (en) * 2004-03-05 2005-09-08 H. Lundbeck A/S Crystalline composition containing escitalopram
EA200601641A1 (ru) * 2004-03-05 2006-12-29 Х. Лундбекк А/С Кристаллическая композиция, содержащая оксалат эсциталопрама
WO2006123243A2 (en) * 2005-05-20 2006-11-23 Aurobindo Pharma Limited Pharmaceutical dosage forms comprising escitalopram in form of granules
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
BRPI0606122A2 (pt) * 2005-08-29 2009-06-02 Teva Pharma tadalafil particulado sólido que tem uma distribuição de tamanho de partìcula bimodal
EP1954257A4 (en) 2005-10-14 2009-05-20 Lundbeck & Co As H METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
GB0601286D0 (en) 2006-01-23 2006-03-01 Sandoz Ag Asymmetric synthesis
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
EP2086509A1 (en) * 2006-10-20 2009-08-12 Ratiopharm GmbH Escitalopram and solid pharmaceutical composition comprising the same
US20090048336A1 (en) * 2007-08-17 2009-02-19 Naveen Kumar Kolla Escitalopram oxalate powders
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
EP2116231A1 (en) 2008-05-07 2009-11-11 Hexal Ag Granulate comprising escitalopram oxalate
GR20080100696A (el) 2008-10-23 2010-05-13 Genepharm �.�. Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
ITMI20120106A1 (it) * 2012-01-30 2013-07-31 Carthesia S A S Pastiglie liofilizzate di escitalopram ossalato per somministrazione sublinguale
ITMI20120448A1 (it) * 2012-01-30 2013-07-31 Carthesia Sas Composizione liofilizzata di escitalopram ossalato per somministrazione sublinguale
CN106389374A (zh) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 一种含有lcz696的药物组合物及其制备方法
JP2018016569A (ja) * 2016-07-26 2018-02-01 株式会社トクヤマ （１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
JP6423133B1 (ja) * 2017-04-10 2018-11-14 東和薬品株式会社 エスシタロプラム医薬組成物
CN107441052A (zh) * 2017-06-21 2017-12-08 山东京卫制药有限公司 一种含有草酸艾司西酞普兰的片剂及其制备方法
KR102089737B1 (ko) 2017-11-01 2020-03-16 한국화학연구원 에씨탈로프람을 함유한 미립구형 서방출 주사제 및 그의 제조방법
JP7453859B2 (ja) 2020-06-22 2024-03-21 東和薬品株式会社 エスシタロプラム錠剤

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (hu) * 1965-03-18
GB1358915A (en) 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8814057D0 (en) 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
GB9325644D0 (en) 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
EP0714663A3 (en) 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
WO1996041633A1 (en) 1995-06-08 1996-12-27 Eli Lilly And Company Methods of treating cold and allergic rhinitis
PT1015416E (pt) 1997-07-08 2002-03-28 Lundbeck & Co As H Metodo para a producao de citalopram
GB9714841D0 (en) 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
US5840334A (en) * 1997-08-20 1998-11-24 Fuisz Technologies Ltd. Self-binding shearform compositions
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
UA62985C2 (en) 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
AU738359B2 (en) * 1997-11-11 2001-09-13 H. Lundbeck A/S Method for the preparation of citalopram
HU228576B1 (en) 1998-10-20 2013-04-29 Lundbeck & Co As H Method for the preparation of citalopram
TWI230618B (en) * 1998-12-15 2005-04-11 Gilead Sciences Inc Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
TR200102957T2 (tr) 1999-04-14 2004-12-21 H. Lundbeck A/S Sitalopram hazırlanması için metod.
ITMI991579A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
EP1220658A1 (en) * 1999-09-28 2002-07-10 H. Lundbeck A/S Melt granulated composition and modified release dosage form prepared from said composition
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
US20030232881A1 (en) * 2000-10-27 2003-12-18 H. Lundbeck A/S Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
ES2280892T3 (es) 2001-07-31 2007-09-16 H. Lundbeck A/S Composicion cristalina que contiene escitalopram.

Also Published As

Publication number Publication date
HRP20031073A2 (en) 2004-04-30
JP2011195591A (ja) 2011-10-06
HK1070000A1 (en) 2005-06-10
PT1522539E (pt) 2007-03-30
JP2010150283A (ja) 2010-07-08
BG108571A (en) 2005-02-28
UA79930C2 (en) 2007-08-10
NZ530157A (en) 2007-06-29
IL159326A (en) 2010-05-31
CA2451915A1 (en) 2003-02-13
CO5560540A2 (es) 2005-09-30
US20030212128A1 (en) 2003-11-13
EP1522539A1 (en) 2005-04-13
AR034898A1 (es) 2004-03-24
UY27404A1 (es) 2003-02-28
WO2003011278A1 (en) 2003-02-13
IS7077A (is) 2003-12-15
DE60217932T2 (de) 2007-08-30
DE60202615T2 (de) 2006-01-12
JP2012211186A (ja) 2012-11-01
US20050147674A1 (en) 2005-07-07
MXPA04000849A (es) 2004-05-14
TNSN04021A1 (en) 2006-06-01
US6916941B2 (en) 2005-07-12
ATE286730T1 (de) 2005-01-15
ZA200309684B (en) 2004-12-22
US20080305164A1 (en) 2008-12-11
JP5192568B2 (ja) 2013-05-08
EP1414435A1 (en) 2004-05-06
MA27349A1 (fr) 2005-06-01
DE60217932D1 (de) 2007-03-15
EP1414435B1 (en) 2005-01-12
HRPK20080410B3 (en) 2009-09-30
DE60202615D1 (de) 2005-02-17
JP5719811B2 (ja) 2015-05-20
EP1522539B1 (en) 2007-01-24
KR20040028947A (ko) 2004-04-03
PL366995A1 (en) 2005-02-07
EG24206A (en) 2008-10-21
ES2233842T3 (es) 2005-06-16
AU2002355624B2 (en) 2006-02-02
MEP2108A (xx) 2010-02-10
CA2451915C (en) 2010-09-21
PT1414435E (pt) 2005-05-31
CN1536997A (zh) 2004-10-13
MY126238A (en) 2006-09-29
CY1106413T1 (el) 2011-10-12
DK1414435T3 (da) 2005-05-09
JP2005525993A (ja) 2005-09-02
BR0206164A (pt) 2003-10-28
TR200400189T2 (tr) 2004-12-21
US7420069B2 (en) 2008-09-02
DK1522539T3 (da) 2007-05-07
EA200400243A1 (ru) 2004-06-24
IL159326A0 (en) 2004-06-01
EA006213B1 (ru) 2005-10-27
NO328346B1 (no) 2010-02-01
PE20030304A1 (es) 2003-03-27
HRP20080410A2 (en) 2008-10-31
JP4971477B2 (ja) 2012-07-11
NO20040380L (no) 2004-01-28
CN1311819C (zh) 2007-04-25
ATE352546T1 (de) 2007-02-15
RS8304A (en) 2006-12-15
ES2280892T3 (es) 2007-09-16
SI1414435T1 (en) 2005-06-30
CN1660074A (zh) 2005-08-31

Similar Documents

Publication Publication Date Title
HUP0401946A2 (hu) Escitalopramot tartalmazó kristályos gyógyszerkészítmény
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
NO20085078L (no) Nye forbindelser
NO20030051D0 (no) Ny <gamma>-krystallinsk form av perindopril tert- butylaminsalt, fremgangsmåte for dens fremstilling og farmasöytiske sammensetningerinneholdende den
DE69940769D1 (de) Orale flüssige zusammensetzungen
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
MY148297A (en) Process for modifying drug crystal formation
DE69920017D1 (de) Neue form vom irbesartan, verfahren um diese form zu erhalten und sie enthaltende pharmazeutische zusammensetzungen
HUP0401451A2 (hu) Eljárás escitalopram elõállítására
NO20030050L (no) Ny <beta>-krystallinsk form av perindopril tert- butylaminsalt, fremgangsmåte for dens fremstilling og farmasöytiske sammensetningerinneholdende den
CY1107451T1 (el) Υδροβρωμικον escitalopram και μεθοδος δια την παρασκευη αυτου
BR0211739A (pt) Novas formas polimórficas cristalinas de cloridrato de lercanidipina e processo para preparação das mesmas
HU229456B1 (en) Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
JP2005538045A5 (hu)
HUP0303737A2 (hu) 6-helyzetben szubsztituált indolinonok és alkalmazásuk kináz inhibitorokként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0300389A2 (hu) A kabergolin II. kristályformája, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
HUP0204005A2 (hu) Pravastatin-nátrium új módosulatai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
EA200601641A1 (ru) Кристаллическая композиция, содержащая оксалат эсциталопрама
ATE308537T1 (de) Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69300453T2 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
BRPI0410026A (pt) derivados de 3-amino-croman quinolina
MXPA04001030A (es) Proceso para la preparacion de isobenzofuranos 5-sustituidos.
ATE282726T1 (de) Herstellung von verbindungen auf basis von cu-in- se phasengleichgewichten
HUP9904526A2 (hu) Piperidinszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees